Specifically, we found that re-expression of SOX9 substantially restored the proliferative and tumorigenic capacity of PRMT7-depleted NSCLC cells both in vitro and in vivo, indicating that the oncogenic function of PRMT7 depends, at least in part, on SOX9. Here, SOX9 is linked to non-small cell lung carcinoma.